Property, Plant and Equipment, Net in USD of Ovid Therapeutics Inc. from Q4 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
Ovid Therapeutics Inc. quarterly Property, Plant and Equipment, Net history and change rate from Q4 2016 to Q3 2025.
  • Ovid Therapeutics Inc. Property, Plant and Equipment, Net for the quarter ending September 30, 2025 was $269K, a 47.2% decline year-over-year.
Property, Plant and Equipment, Net, Quarterly (USD)
Property, Plant and Equipment, Net, YoY Quarterly Change (%)

Ovid Therapeutics Inc. Quarterly Property, Plant and Equipment, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $269K -$240K -47.2% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $285K -$333K -53.9% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $346K -$340K -49.6% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $433K -$336K -43.7% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $509K -$347K -40.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $618K -$338K -35.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $686K -$367K -34.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $769K -$379K -33% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $856K -$303K -26.1% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $956K -$288K -23.1% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $1.05M +$795K +308% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $1.15M +$905K +373% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $1.16M +$1.05M +1008% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.24M +$1.13M +994% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $258K +$129K +101% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $243K +$107K +79% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $105K -$33.1K -24% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $114K -$2.33K -2.01% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $128K +$19.5K +17.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $136K +$67.3K +98.4% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $138K +$65.6K +90.7% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $116K +$57.2K +97.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $109K +$42.9K +64.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $68.4K -$1.5K -2.15% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $72.2K +$4.09K +6% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $58.8K -$8.88K -13.1% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $66.2K +$14.1K +27% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $69.9K +$18.1K +34.9% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $68.2K +$16.4K +31.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $67.7K +$17.9K +35.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $52.1K +$5.5K +11.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $51.8K +$8.18K +18.8% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $51.7K Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $49.8K Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $46.6K Mar 31, 2017 10-Q 2017-06-13
Q4 2016 $43.6K Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.